Editorial & Opinion
Anti-rubella IgG serum levels predict risk for SARS-CoV-2 breakthrough infections.
| العنوان: | Anti-rubella IgG serum levels predict risk for SARS-CoV-2 breakthrough infections. |
|---|---|
| المؤلفون: | Hollstein MM; Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany., Dierks S; Department of Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany.; Interdisciplinary UMG Laboratory, University Medical Center Göttingen, Göttingen, Germany., Schön MP; Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.; Lower Saxony Institute of Occupational Dermatology, University Medical Center Göttingen, Göttingen, Germany., Groß U; Interdisciplinary UMG Laboratory, University Medical Center Göttingen, Göttingen, Germany.; Institute of Medical Microbiology and Virology, University Medical Center Göttingen, Göttingen, Germany., Thiele K; Department of Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany.; Interdisciplinary UMG Laboratory, University Medical Center Göttingen, Göttingen, Germany., Leha A; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany., Zautner AE; Institute of Medical Microbiology and Virology, University Medical Center Göttingen, Göttingen, Germany.; Institute of Medical Microbiology and Hospital Hygiene, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.; Center for Health and Medical Prevention (CHaMP), Otto-von-Guericke University Magdeburg, Magdeburg, Germany., Fischer A; Department of Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany.; Interdisciplinary UMG Laboratory, University Medical Center Göttingen, Göttingen, Germany., Erpenbeck L; Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.; Department of Dermatology, University of Münster, Münster, Germany., Schnelle M; Department of Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany.; Interdisciplinary UMG Laboratory, University Medical Center Göttingen, Göttingen, Germany. |
| المصدر: | Allergy [Allergy] 2024 Jul 09. Date of Electronic Publication: 2024 Jul 09. |
| Publication Model: | Ahead of Print |
| نوع المنشور: | Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Copenhagen : Wiley-Blackwell Original Publication: Copenhagen, Munksgaard. |
| References: | Accorsi EK, Britton A, Fleming‐Dutra KE, et al. Association between 3 doses of mRNA COVID‐19 vaccine and symptomatic infection caused by the SARS‐CoV‐2 omicron and delta variants. JAMA. 2022;327(7):639‐651. doi:10.1001/jama.2022.0470. Lipsitch M, Krammer F, Regev‐Yochay G, Lustig Y, Balicer RD. SARS‐CoV‐2 breakthrough infections in vaccinated individuals: measurement, causes and impact. Nat Rev Immunol. 2022;22(1):57‐65. doi:10.1038/s41577-021-00662-4. Liu Y, Liu P, Sun Y, Deng G. Clinical characteristics, outcomes, and risk factors of SARS‐CoV‐2 breakthrough infections among 572 fully vaccinated (BBIBP‐CorV) hospitalized patients. Heliyon. 2023;9(11):e21387. doi:10.1016/j.heliyon.2023.e21387. Hollstein MM, Dierks S, Schön MP, et al. Humoral and cellular immune responses in fully vaccinated individuals with or without SARS‐CoV‐2 breakthrough infection: results from the CoV‐ADAPT cohort. J Med Virol. 2023;95(10):e29122. doi:10.1002/jmv.29122. Nakaharai K, Nakazawa Y, Mishima Y, Saito M, Shinozaki Y, Yoshida M. Association between a low response to rubella vaccination and reduced anti‐severe acute respiratory syndrome coronavirus 2 immune response after vaccination with BNT162b2: a cross‐sectional study. Clin Microbiol Infect. 2023;29(2):253.e1‐253.e5. doi:10.1016/j.cmi.2022.09.007. Hollstein MM, Münsterkötter L, Schön MP, et al. Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS‐CoV‐2 vaccination. Allergy. 2022;77(8):2381‐2392. doi:10.1111/all.15247. Hollstein MM, Münsterkötter L, Schön MP, et al. Long‐term effects of homologous and heterologous SARS‐CoV‐2 vaccination on humoral and cellular immune responses. Allergy. 2022;77(8):2560‐2564. doi:10.1111/all.15373. |
| معلومات مُعتمدة: | ER723/3-1 German Research Foundation Deutsche Forschungsgemeinschaft; TRR332 German Research Foundation Deutsche Forschungsgemeinschaft |
| تواريخ الأحداث: | Date Created: 20240709 Latest Revision: 20240709 |
| رمز التحديث: | 20240709 |
| DOI: | 10.1111/all.16232 |
| PMID: | 38979807 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1398-9995 |
|---|---|
| DOI: | 10.1111/all.16232 |